Dr Laura Blackburn
Head of Science
Laura is PHG Foundation's Head of Science, and is responsible for the delivery of the scientific expertise and analysis that underpin our work. She also contributes to the development of our strategic partnerships with other organisations who have an interest in science and health policy. Current projects include exploring the opportunities and challenges highlighted in our 2018 report 'The personalised medicine technology landscape' with a range of stakeholders, contributing to the Foundation's work on clinical applications of genome editing and working with key contacts to understand the key implementation challenges influencing the use of circulating tumour DNA technologies and developing policies to mitigate these.
Laura has a background in Zoology and extensive science writing and communication experience from previous roles including at the Cancer Research UK Cambridge Institute. An interest in the challenges involved in translating research into the clinic led Laura to her role at PHG Foundation. Before becoming Head of Science Laura contributed her expertise in explaining complex scientific concepts and policy implications to projects on emerging technologies and assists with our public affairs work.
- Reports
- Policy briefings
-
Citizen generated data: the ethics of remote patient monitoring
-
ctDNA technology in lung cancer: personalised healthcare in action
-
Circulating tumour DNA technology: the future of cancer management?
-
Protecting patients from healthcare associated infections: a role for genomics
-
Genomics for infection control: meeting local and national needs
-
Genomics and the management of antimicrobial resistance: current successes and future challenges
- Consultation responses
- Blogs
-
An eye to the future: review of screening programmes in England
-
Regenerative medicines – can the Government and the NHS deliver?
-
Clinical proteome analysis - the key to personalised medicine
-
Circulating tumour DNA technology-the future of cancer management?
-
The global battle against AMR - can technology lead the way?
-
Epigenome analysis: Another tool in the personalised medicine kit?
-
Infection control leads the way for the use of pathogen genomics
-
TB in England: moving closer to deployment of whole genome sequencing
-
An integrated strategy for implementing infectious disease genomics
-
Genome sequencing sheds light on deadly antibiotic resistant hospital infections
- Journal papers
-
Melissa Hill; Sian Ellard; Jane Fisher; Naomi Fulop; Marian Knight; Mark Kroese; Jean Ledger; Kerry Leeson-Beevers; Alec McEwan; Dominic McMullan; Laura Blackburn et al. [version 2; peer review: 2 approved]. NIHR Open Res 2022, 2:10
-
Moorthie S, Hall A, Babb de Villiers C, Janus J, Brigden T, Blackburn L, Kroese M. Future Medicine. 15 March 2022.